Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer.

about

Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer.

Item

http://www.wikidata.org/entity/Q43623151

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Potential therapeutic effect o ...... euroendocrine prostate cancer.

@en

Potential therapeutic effect o ...... euroendocrine prostate cancer.

@nl

type

Item

label

Potential therapeutic effect o ...... euroendocrine prostate cancer.

@en

Potential therapeutic effect o ...... euroendocrine prostate cancer.

@nl

prefLabel

Potential therapeutic effect o ...... euroendocrine prostate cancer.

@en

Potential therapeutic effect o ...... euroendocrine prostate cancer.

@nl

P1476

Potential therapeutic effect o ...... euroendocrine prostate cancer.

@en

P2093

Alexa Cohen

http://www.w3.org/2001/XMLSchema#string

Jiao-Ti Huang

http://www.w3.org/2001/XMLSchema#string

Jill Squires

http://www.w3.org/2001/XMLSchema#string

Min Zhang

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Xiang Xu

http://www.w3.org/2001/XMLSchema#string

Xu-Feng Chen

http://www.w3.org/2001/XMLSchema#string

Yan-Jing Li

http://www.w3.org/2001/XMLSchema#string

Yu-Hua Huang

http://www.w3.org/2001/XMLSchema#string

Zhen Li

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes

Therapies targeting cancer stem cells: Current trends and future challenges

Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure

Targeting prostate cancer stem cells for cancer therapy

Prostate Cancer Stem Cells: Research Advances

Global cancer statistics, 2012

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future.

Neuroendocrine cells in tumour growth of the prostate.

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and Un

P304

686-693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1008-682X.191518

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27905327

http://www.w3.org/2001/XMLSchema#string

P932

5676429

http://www.w3.org/2001/XMLSchema#string